Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Ligand Pharmaceuticals Inc.    LGND

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Ligand Pharmaceuticals Inc. : SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Ligand Pharmaceuticals Incorporated

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/17/2013 | 06:55pm CET

NEW YORK, May 17, 2013 /PRNewswire/ -- Levi & Korsinsky, LLP is investigating Ligand Pharmaceuticals Incorporated (NasdaqGM: LGND), and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)

To get more information, click here: http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/. There is no cost or obligation to you.

If you own common stock in Ligand Pharmaceuticals Incorporated and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at ek@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/ligand-pharmaceuticals-lgnd/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on LIGAND PHARMACEUTICALS INC
12/07 LIGAND PHARMACEUTICALS INC. : INVESTOR NOTICE: Lundin Law PC Announces Securitie..
12/07 LIGAND PHARMACEUTICALS INC. : Levi & Korsinsky, LLP Notifies Shareholders of Lig..
12/07 LAWSUIT FOR INVESTORS IN SHARES OF L : LGND) in Effort to Recover Losses Filed
12/06 LIGAND PHARMACEUTICALS INC. : Khang & Khang LLP Announces Securities Class Actio..
12/06 LIGAND PHARMACEUTICALS INC. : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman,..
12/05 LIGAND PHARMACEUTICALS INC. : SHAREHOLDER NOTICE: Lundin Law PC Announces Securi..
12/05 LGND NOTICE : Rosen Law Firm Reminds Ligand Pharmaceuticals Incorporated Investo..
12/01 LIGAND PHARMACEUTICALS INC. : Khang & Khang LLP Announces Securities Class Actio..
12/01 Lundin Law PC Announces Securities Class Action Lawsuit against Ligand Pharma..
11/30 LIGAND PHARMACEUTICALS INC. : Khang & Khang LLP Announces Securities Class Actio..
More news
Sector news : Biotechnology & Medical Research - NEC
12/03DJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
11/30 ACTELION : Rejecting J&J could leave Actelion with 'lot of explaining to do'
11/28 Actelion's ambitious independent-minded CEO will drive up takeover price
11/26DJWHAT'S NEWS : Business & Finance -- WSJ
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
11/27 INSIDERINSIGHTS.COM DAILY ROUND UP 1 : Frsh, prgx, opk
11/14 BEST NEAR-TERM PRICE GAINS AHEAD FOR : Biotechnology Developers Stocks
11/03 Ligand Pharmaceuticals' (LGND) CEO John Higgins on Q3 2016 Results - Earnings..
11/03 Ligand Pharmaceuticals beats by $0.03, misses on revenue
11/02 Notable earnings after Thursday?s close